How Long Does GLOW Last? Shelf Life & Stability
"Stable" is meaningless without saying stable against what. GLOW has its own set of degradation routes, and they determine which storage precautions actually matter for it.
In plain English
Three ingredients, three separate clocks. The copper can come off the GHK-Cu in acidic conditions or if a chelating agent like EDTA gets near it. The TB-500 slowly reacts with oxygen. The BPC-157 is the toughest of the three. So the blend keeps for as long as its weakest link, not its strongest.
What GLOW actually is
GLOW is three well-known research compounds freeze-dried together in a single 70 mg vial: GHK-Cu at 50 mg, BPC-157 at 10 mg and TB-500 at 10 mg. Each is studied separately elsewhere, and each works through a different mechanism — collagen and skin matrix for GHK-Cu, blood vessel formation for BPC-157, cell movement for TB-500.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Degradation routes specific to GLOW
- Copper dissociation from the GHK-Cu component at acidic pH or on contact with chelators such as EDTA — visible as the blue colour fading, and the single most consequential failure mode given GHK-Cu is 71% of the fill.
- Methionine oxidation in the TB-500 component (+16 Da), accelerated by light and dissolved oxygen.
- Slow aspartate isomerisation in the BPC-157 component over extended solution storage.
- Divergent component degradation shifting the 50/10/10 ratio even while total peptide content stays high.
Because GHK-Cu dominates, GLOW behaves far more like a copper-peptide preparation than like a generic peptide blend. Apply GHK-Cu handling rules first and the rest follows.
Freeze–thaw tolerance
Aliquot on reconstitution. The three components degrade on independent schedules, so repeated cycles shift the ratio as well as reducing total content.
How storage addresses these routes
Practical window once reconstituted: 2–3 weeks at 2–8 °C — set by TB-500 and GHK-Cu rather than by BPC-157, which alone would tolerate longer. Protect from light — required by both the GHK-Cu and TB-500 components.
Full GLOW storage conditionsWhat GLOW is studied for
The majority component, with the deepest dermal literature — collagen and glycosaminoglycan synthesis in fibroblast models.
Studied around vessel formation and growth-factor pathways in tissue-repair models.
Actin sequestration and directed cell movement — how cells reach a tissue defect.
The three components act through genuinely non-overlapping mechanisms, which is the rationale for combining them.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More GLOW reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Stability reference for other compounds
GLOW is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.